Record number :
2398314
Title of article :
Management of Retinal Vein Occlusion, Who Is Responsible?
Author/Authors :
Aghamirsalim، Mohamadreza نويسنده Department of Ophthalmology, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. AND Students’ Scientific Research Center (SSRC), Exceptional Talent Development Center (ETDC), Tehran University of Medical Sciences, Tehran, Iran. Aghamirsalim, Mohamadreza , Sorbi، Reza نويسنده Students’ Scientific Research Center (SSRC), Exceptional Talent Development Center (ETDC), Tehran University of Medical Sciences, Tehran, Iran. Sorbi, Reza , Naderian، Mohammadreza نويسنده Students’ Scientific Research Center (SSRC), Exceptional Talent Development Center (ETDC), Tehran University of Medical Sciences, Tehran, Iran. AND Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Naderian, Mohammadreza , Cugati، Sudha نويسنده Department of Ophthalmology, University of Adelaide, Adelaide, Australia. Cugati, Sudha , Shahsuvaryan، Marianne Levon نويسنده Department of Ophthalmology, Yerevan State Medical University, Armenia. Shahsuvaryan, Marianne Levon , Ghazizadeh Hashemi، Maryam نويسنده Department of Psychiatry, Rasoul-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. Ghazizadeh Hashemi, Maryam
Issue Information :
ماهنامه با شماره پیاپی 0 سال 2016
Pages :
6
From page :
731
To page :
736
Abstract :

Retinal vein occlusion (RVO) is a common retinal vascular occlusive disorder and is associated with a variety of systemic risk factors. The aim of this study was to investigate whether the underlying diseases were evaluated and managed appropriately by ophthalmologists. We performed a study of 1344 patients with retinal vein occlusion (RVO). Patients were evaluated with a questionnaire including ten closed questions to determine whether ophthalmologists evaluated and informed their patients about the underlying systemic diseases. None of the patients’ homocysteine levels were measured. Only a small percentage of the patients were asked about the history of thrombotic diseases or family history of thrombotic diseases. We believe that most ophthalmologists are still not entirely convinced of their responsibility of managing the underlying predisposing factors of RVO. Ophthalmologists should either manage or engage other healthcare providers in the management of RVO to guarantee the patient the best care.

Journal title :
Acta Medica Iranica
Serial Year :
2016
Link To Document :
بازگشت